XML 39 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Investments and fair value measurements (Tables)
9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Schedule of Investments on Condensed Consolidated Balance Sheets
The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy (in thousands):
As of September 30, 2024
Level 1Level 2Level 3
Assets
Cash equivalents1:
Money market funds$160,819 $— $— 
Time deposits6,445 — — 
Marketable securities:
U.S. government securities— 152,546 — 
Strategic investments— — — 
Total assets
$167,264 $152,546 $— 
Liabilities
Accrued expenses and other current liabilities:
Cash settled stock appreciation rights
$— $— $
Other liabilities, non-current:
Cash settled stock appreciation rights— — 
Total liabilities
$— $— $10 

As of December 31, 2023
Level 1Level 2Level 3
Assets
Cash equivalents1:
Money market funds$266,692 $— $— 
Marketable securities:
U.S. government securities— 171,372 — 
Strategic investments— — 10,311 
Total assets
$266,692 $171,372 $10,311 
Other liabilities, non-current:
Cash settled stock appreciation rights$— $— $48 
(1) Included in cash and cash equivalents in the accompanying condensed consolidated balance sheets, in addition to $37.3 million and $38.9 million of cash, as of September 30, 2024 and December 31, 2023, respectively.
Schedule of Investments on Condensed Consolidated Balance Sheets
The following tables present the Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy (in thousands):
As of September 30, 2024
Level 1Level 2Level 3
Assets
Cash equivalents1:
Money market funds$160,819 $— $— 
Time deposits6,445 — — 
Marketable securities:
U.S. government securities— 152,546 — 
Strategic investments— — — 
Total assets
$167,264 $152,546 $— 
Liabilities
Accrued expenses and other current liabilities:
Cash settled stock appreciation rights
$— $— $
Other liabilities, non-current:
Cash settled stock appreciation rights— — 
Total liabilities
$— $— $10 

As of December 31, 2023
Level 1Level 2Level 3
Assets
Cash equivalents1:
Money market funds$266,692 $— $— 
Marketable securities:
U.S. government securities— 171,372 — 
Strategic investments— — 10,311 
Total assets
$266,692 $171,372 $10,311 
Other liabilities, non-current:
Cash settled stock appreciation rights$— $— $48 
(1) Included in cash and cash equivalents in the accompanying condensed consolidated balance sheets, in addition to $37.3 million and $38.9 million of cash, as of September 30, 2024 and December 31, 2023, respectively.
Schedule of the Changes in the Fair Value of Level 3 Financial Instruments
A summary of the changes in the fair value of Level 3 financial instruments, of which vesting and remeasurement of stock appreciation rights (SARs) and impairment of strategic investments are recognized in the consolidated statements of operations, is as follows (in thousands):
Stock Appreciation RightsStrategic Investments
Balance— June 30, 2024
$16 $— 
Vesting and remeasurement of SARs(6)— 
Balance— September 30, 2024
$10 $— 
Balance— June 30, 2023
$30 $10,311 
Vesting and remeasurement of SARs(4)— 
Balance— September 30, 2023
$26 $10,311 
Balance— December 31, 2023
$48 $10,311 
Vesting and remeasurement of SARs(31)— 
Exercises of SARs(7)— 
Unrealized loss on strategic investments— (10,311)
Balance— September 30, 2024
$10 $— 
Balance— December 31, 2022
$462 $12,104 
Vesting and remeasurement of SARs(183)— 
Exercises of SARs(253)— 
Unrealized loss on strategic investments— (1,793)
Balance— September 30, 2023
$26 $10,311 
Schedule of the Changes in the Fair Value of Level 3 Financial Instruments
A summary of the changes in the fair value of Level 3 financial instruments, of which vesting and remeasurement of stock appreciation rights (SARs) and impairment of strategic investments are recognized in the consolidated statements of operations, is as follows (in thousands):
Stock Appreciation RightsStrategic Investments
Balance— June 30, 2024
$16 $— 
Vesting and remeasurement of SARs(6)— 
Balance— September 30, 2024
$10 $— 
Balance— June 30, 2023
$30 $10,311 
Vesting and remeasurement of SARs(4)— 
Balance— September 30, 2023
$26 $10,311 
Balance— December 31, 2023
$48 $10,311 
Vesting and remeasurement of SARs(31)— 
Exercises of SARs(7)— 
Unrealized loss on strategic investments— (10,311)
Balance— September 30, 2024
$10 $— 
Balance— December 31, 2022
$462 $12,104 
Vesting and remeasurement of SARs(183)— 
Exercises of SARs(253)— 
Unrealized loss on strategic investments— (1,793)
Balance— September 30, 2023
$26 $10,311